Cambridge, MA, United States of America

Padmaja Yerramilli-Rao

USPTO Granted Patents = 3 

 

 

Average Co-Inventor Count = 4.6

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Padmaja Yerramilli-Rao: Innovator in Cancer Treatment

Introduction

Padmaja Yerramilli-Rao is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of cancer treatment, particularly through her work on protein kinase C inhibitors. With a total of 3 patents, her innovations are paving the way for new therapeutic approaches.

Latest Patents

Her latest patents focus on the use of protein kinase C (PKC) inhibitors for the treatment and prevention of proliferative diseases, including uveal melanoma. The disclosures relate to various pharmaceutical formulations, methods, and combinations that utilize PKC inhibitors alongside other therapeutic agents, such as MDM2 inhibitors. These advancements hold promise for improving treatment outcomes for patients suffering from proliferative diseases.

Career Highlights

Padmaja Yerramilli-Rao is currently associated with Novartis AG, where she continues to drive innovation in cancer therapies. Her work is characterized by a commitment to developing effective treatments that can significantly impact patient care.

Collaborations

She collaborates with esteemed colleagues, including Vesselina Cooke and Michael Scott Visser, to further enhance the research and development of her innovative solutions.

Conclusion

Padmaja Yerramilli-Rao's contributions to the field of cancer treatment through her patented innovations exemplify her dedication to improving patient outcomes. Her work continues to inspire advancements in medical research and therapeutic development.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…